How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Close this folder6 DEVELOPING SPECIFIC INFORMATION SECTIONS
View the documentCreating locally important appendices
Open this folder and view contentsAdopting appendices from the WHO model formulary
Open this folder and view contentsWorking with a master document in Microsoft Word® to create a table of contents and index
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Creating locally important appendices

When planning the topics and the content of individual appendices, the purpose and the intended audience of the NF should be borne in mind. It is likely a number of additional appendices will need to be developed for each country (see Table 6.1). The main focus of the individual appendices should be agreed upon by the NFC in the initial planning stage. The members of the advisory group should also comment at an early stage on the planned appendices; useful suggestions on inclusion of locally important information often come from these potential users.

Table 6.1. Examples of different types of information presented in appendices of a NF

Main category

Examples

Therapeutic and safety information

1. Interactions,a e.g. medicine-medicine, medicine-food/herb, medicine-diagnostic test
2. Medicine use and prescribinga in special patient populations i.e. during pregnancy,a breastfeeding,a renala and hepatic impairmenta
3. Pharmacokinetic data, dosing guidelines for medicines with narrow therapeutic index (e.g. digoxin, aminoglycosides) and therapeutic drug monitoring informationb
4. Dose calculators, nomograms (e.g. for paediatric dose and emergency medicine dose calculations, dilutions)b
5. Protocols for emergency treatment of common poisonings

Pharmaceutical information

1. Pharmaceutical incompatibilities, guidance on intravenous additives, instructions for specific intravenous infusions
2. Standard parenteral nutrition formulas
3. Electrolyte content of large-volume parenterals
4. List of sugar-free products

Administrative information

1. List of miscellaneous items i.e. food supplements, surgical dressings etc.
2. Lists of medicines restricted to special prescribing practices, e.g. narcotics, anticancer medicines, intravenous antibiotics etc. and examples of special prescription forms and instructions for completing them; definitions of who is authorized to prescribe them
3. Model texts for labelling of medicines, and other dispensary information, i.e. cautionary and advisory labels
4. Instructions for reporting of adverse drug reactions (ADRs), reporting form and list of medicines for which all ADRs are to be reported
5. Form for submission of recommendation for addition/deletions/corrections to the formulary
6. Reference list of national clinical treatment guidelines
7. Contact details of national drug information and poison control centres
8. Contact details of essential medicine suppliers and procurement agencies

 

a This type of information is presented in the WMF in Appendices I-V.
b A limited amount of this type of information is given in the WMF.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014